Clinical Trial Update: Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites [NA]

View source ↗

Summary

A completed clinical trial evaluating topical heparin to prevent hypertrophic scarring at split-thickness skin graft donor sites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scarring

Drugs mentioned

• Topical Heparin (heparin (topical))

Snippet

Sponsor: Dr. Ruth K.M. Pfau Civil Hospital, Karachi | Conditions: Hypertrophic Scarring, Pain, Postoperative | NA | Status: COMPLETED